With over 35 years in the reproductive medicine industry, Bernadette brings a wealth of experience to the partnership, said Jens Sønksen when welcoming her to ReproUnion’s Executive Board in the autumn 2021.
The first week of November marks the European Fertility Week – and this year, for the first time ever, it is shedding light on male infertility issues and men’s health. More than 25 million citizens in the European Union are facing fertility issues today with male factor infertility occurring in around 40% of all infertile couples.
ReproUnion supported PhD brings new knowledge on the imprint men and women risk leaving on their future children from smoking and exposure to PFAS
The world’s largest male offspring cohort to examine the fetal origin of adult reproductive function (FEPOS) was established as part of Katia Keglberg Hærvig’s PhD project, funded by ReproUnion.
On the 4th of August Nature published the findings from a global collaboration of scientists, who have identified nearly 300 gene variations that influence reproductive lifespan in women. This can lead to potential new targets for fertility treatments as well as ways to improve the prediction of early menopause.
In collaboration with scientists from 20 Universities around the world, ReproUnion colleagues at Rigshospitalet have uncovered how a gen-mutation is a reason for missing sperm cells. This is for the first time described in relation to infertility in a newly published article in the prestigious New England Journal of Medicine
In June, the message about the ReproUnion Biobank and Infertility Cohort (RUBIC) spread across Danish, Swedish and scientific media – exactly one year after RUBIC enrolled the first infertile couples!
ReproUnion supported PhD adds novel insights to how genetic and epigenetic variations influence testicular function
In her PhD Nina Mørup Nygaard researched how both common and rare genetic variants play different, but significant roles for male reproduction. She further investigated how small non-coding RNAs can serve as biomarkers for testicular cancer and her results have been covered by various publications.
It is with great sadness that we received the news that Professor Bernard Jégou from Rennes, France, has passed away on the 11th of May 2021. Bernard Jegou was one of the world’s leading reproductive researchers and a person with whom scientific collaboration quickly developed into a friendship.
The Novo Nordisk Foundation grants DKK 10 mio to introduce genetics and personalised medicine for improved fertility treatment
With their RESPOND project, Professors Eva Hoffmann and Anja Pinborg have received DKK 10 million from the Novo Nordisk Foundation and its Tandem Programme, which seeks to stimulate the transition...
On the 8th of April 2021, Professor Eva Hoffmann was among the first presenters at the virtual ’Best of ASRM & ESHRE 2021’ conference with her lecture on Molecular mechanisms behind women’s...